Onyou Hwang
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Correction: Crif1 deficiency in dopamine neurons triggers early-onset parkinsonism.
Journal: Molecular psychiatry
Published: October 02, 2023
Pyruvate Prevents Dopaminergic Neurodegeneration and Motor Deficits in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease.
Journal: Molecular neurobiology
Published: April 25, 2022
A novel pyrazolo [3,4-d] pyrimidine, KKC080106, activates the Nrf2 pathway and protects nigral dopaminergic neurons.
Journal: Experimental neurology
Published: December 09, 2019
Aberrant Tonic Inhibition of Dopaminergic Neuronal Activity Causes Motor Symptoms in Animal Models of Parkinson's Disease.
Journal: Current biology : CB
Published: September 03, 2019
The Novel Neuroprotective Compound KMS99220 Has an Early Anti-neuroinflammatory Effect via AMPK and HO-1, Independent of Nrf2.
Journal: Experimental neurobiology
Published: August 16, 2018
Activation of the Nrf2 signaling pathway and neuroprotection of nigral dopaminergic neurons by a novel synthetic compound KMS99220.
Journal: Neurochemistry international
Published: August 16, 2017
Potential repositioning of exemestane as a neuroprotective agent for Parkinson's disease.
Journal: Free radical research
Published: August 04, 2017
Crif1 deficiency in dopamine neurons triggers early-onset parkinsonism.
Journal: Molecular psychiatry
Published: March 15, 2017
Rogdi Defines GABAergic Control of a Wake-promoting Dopaminergic Pathway to Sustain Sleep in Drosophila.
Journal: Scientific reports
Published: January 30, 2017
A novel synthetic isothiocyanate ITC-57 displays antioxidant, anti-inflammatory, and neuroprotective properties in a mouse Parkinson's disease model.
Journal: Free radical research
Published: September 07, 2016
Last Updated: 09/26/2026